Skip to main content
All lobbying firms

REINECKE STRATEGIC SOLUTIONS, INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$440,000 Income reported
5 Clients represented
26 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. 1 filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the registrant's LDA id (298012), not by name.

 Clients 5
 Lobbyists named 1
  • PETER REINECKE 24 filings · through 2026 Sen

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $140,000 8 filings
  • 2025 $300,000 18 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 23
  • SENATE 23
  • Food & Drug Administration (FDA) 8
  • Commerce, Dept of (DOC) 6
  • U.S. Trade Representative (USTR) 6
  • Centers For Medicare and Medicaid Services (CMS) 4
 Recent filings 27 total
Q2 report
CAMPAIGN FOR TOBACCO FREE KIDS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 20, 2026
View →
Q2 report
BONE HEALTH AND OSTEOPOROSIS FOUNDATION (FKA) NATIONAL OSTEOPOROSIS FOUNDATION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 20, 2026
View →
Q2 report
PHARMAVITE LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 20, 2026
View →
Q2 report
UNITED NATURAL PRODUCTS ALLIANCE
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 20, 2026
View →
Q1 report
BONE HEALTH AND OSTEOPOROSIS FOUNDATION (FKA) NATIONAL OSTEOPOROSIS FOUNDATION
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $10,000 income · posted Apr 10, 2026
View →
Q1 report
PHARMAVITE LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 10, 2026
View →
Q1 report
UNITED NATURAL PRODUCTS ALLIANCE
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $10,000 income · posted Apr 10, 2026
View →
Q1 report
CAMPAIGN FOR TOBACCO FREE KIDS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $10,000 income · posted Apr 10, 2026
View →
Q4 report
CAMPAIGN FOR TOBACCO FREE KIDS
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $10,000 income · posted Jan 12, 2026
View →
Q4 amendment
UNITED NATURAL PRODUCTS ALLIANCE
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $10,000 income · posted Jan 12, 2026
View →
Q4 reportNo activity
BONE HEALTH AND OSTEOPOROSIS FOUNDATION (FKA) NATIONAL OSTEOPOROSIS FOUNDATION
4th Quarter 2025 (Oct 1 - Dec 31) · $10,000 income · posted Jan 12, 2026
View →
Q4 report
PHARMAVITE LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 12, 2026
View →
Q4 report
UNITED NATURAL PRODUCTS ALLIANCE Amended
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $10,000 income · posted Jan 12, 2026
View →
Q3 report
PHARMAVITE LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 13, 2025
View →
Q3 report
BONE HEALTH AND OSTEOPOROSIS FOUNDATION (FKA) NATIONAL OSTEOPOROSIS FOUNDATION
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 13, 2025
View →
Q3 report
CAMPAIGN FOR TOBACCO FREE KIDS
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 13, 2025
View →
Q3 report
UNITED NATURAL PRODUCTS ALLIANCE
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 13, 2025
View →
Q2 report
BONE HEALTH AND OSTEOPOROSIS FOUNDATION (FKA) NATIONAL OSTEOPOROSIS FOUNDATION
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 3, 2025
View →
Q2 report
CAMPAIGN FOR TOBACCO FREE KIDS
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 3, 2025
View →
Q2 report
PHARMAVITE LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 3, 2025
View →

Showing the 20 most recent of 27 filings. Search the explorer for "REINECKE STRATEGIC SOLUTIONS, INC.".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem